Professor Chris Abell FRS, FMedSci (1957 – 2020)

Professor Chris Abell FRS, FMedSci (1957 – 2020)

Sphere Fluidics is greatly saddened to share the news that our co-founder and Chairman of our Scientific Advisory Board, Professor Chris Abell, has suddenly passed away. Professor Abell was also the Pro-Vice-Chancellor for Research and Professor of Biological Chemistry at the University of Cambridge. 

Dr. Frank F. Craig, CEO, Sphere Fluidics, said: “As a world-leading scientist, Chris has been responsible for significant advances in his field. His two main areas of research being fragment-based drug discovery and droplet-based microfluidics. He has also been immensely successful in commercialising his work, resulting in the creation of Astex Technology Ltd (1999), Akubio (2001), Sphere Fluidics (2010) and Aqdot (2013). His outstanding scientific ability has contributed to new research and created numerous jobs for the Cambridge community, demonstrating his lasting impact on the pharmaceutical industry. He will be remembered by us all at Sphere Fluidics as an inspirational scientist, colleague and friend that we will greatly miss.”